PPA
AMPH icon

Parametric Portfolio Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Parametric Portfolio Associates’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$12.2M Buy
339,347
+174,951
+106% +$4.96M 0.01% 1240
2021
Q4 		$3.83M Buy
164,396
+13,608
+9% +$278K ﹤0.01% 2044
2021
Q3 		$2.87M Sell
150,788
-1,242
-0.8% -$24.3K ﹤0.01% 2191
2021
Q2 		$3.06M Buy
152,030
+41,544
+38% +$783K ﹤0.01% 2176
2021
Q1 		$2.02M Buy
110,486
+10,027
+10% +$186K ﹤0.01% 2772
2020
Q4 		$2.02M Sell
100,459
-16,509
-14% -$321K ﹤0.01% 2645
2020
Q3 		$2.19M Buy
116,968
+2,588
+2% +$52.1K ﹤0.01% 2459
2020
Q2 		$2.57M Buy
114,380
+28,411
+33% +$520K ﹤0.01% 2343
2020
Q1 		$1.28M Sell
85,969
-33,637
-28% -$585K ﹤0.01% 2657
2019
Q4 		$2.31M Sell
119,606
-37,042
-24% -$711K ﹤0.01% 2599
2019
Q3 		$3.11M Sell
156,648
-15,008
-9% -$313K ﹤0.01% 2370
2019
Q2 		$3.62M Buy
171,656
+14,324
+9% +$299K ﹤0.01% 2240
2019
Q1 		$3.21M Sell
157,332
-46,495
-23% -$1.04M ﹤0.01% 2318
2018
Q4 		$4.06M Buy
203,827
+88,021
+76% +$1.74M ﹤0.01% 2058
2018
Q3 		$2.23M Buy
115,806
+54,014
+87% +$963K ﹤0.01% 2642
2018
Q2 		$943K Sell
61,792
-13,340
-18% -$233K ﹤0.01% 3090
2018
Q1 		$1.41M Buy
75,132
+3,950
+6% +$74.3K ﹤0.01% 2824
2017
Q4 		$1.37M Buy
71,182
+22,391
+46% +$418K ﹤0.01% 2848
2017
Q3 		$872K Buy
48,791
+3,176
+7% +$52.2K ﹤0.01% 3112
2017
Q2 		$815K Buy
45,615
+19,091
+72% +$303K ﹤0.01% 3095
2017
Q1 		$385K Sell
26,524
-37,621
-59% -$592K ﹤0.01% 3331
2016
Q4 		$1.18M Buy
64,145
+1,912
+3% +$37.2K ﹤0.01% 2730
2016
Q3 		$1.18M Buy
62,233
+4,888
+9% +$88.7K ﹤0.01% 2704
2016
Q2 		$924K Buy
57,345
+10,576
+23% +$149K ﹤0.01% 2879
2016
Q1 		$561K Buy
46,769
+4,731
+11% +$55.8K ﹤0.01% 3270
2015
Q4 		$598K Buy
42,038
+26,029
+163% +$344K ﹤0.01% 3134
2015
Q3 		$187K Buy
+16,009
New +$240K ﹤0.01% 3104

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parametric Portfolio Associates's AMPH Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Amphastar Pharmaceuticals (AMPH) stake by 106% in Q1 2022, buying an estimated $4.96M and bringing the position to 339,347 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1240.

Parametric Portfolio Associates first reported a position in AMPH in Q3 2015 and has held it in 27 quarters since. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Parametric Portfolio Associates held 339,347 shares of Amphastar Pharmaceuticals worth $12.2M as of Q1 2022.
  • Parametric Portfolio Associates bought 174,951 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $4.96M.
  • Amphastar Pharmaceuticals made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1240 holding.
  • Parametric Portfolio Associates first reported a position in Amphastar Pharmaceuticals in Q3 2015 and has held it in 27 quarters since.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.